The US Food and Drug Administration may be close to approving prescription drugs derived from marijuana. It was almost 25 years ago, that the FDA first approved pot-based drugs, but now other derivatives may soon show up on pharmacy shelves nationwide thanks to the research efforts of UK- based GW Pharma.
The company is now in advanced trials for the world’s first drug made from raw marijuana. The drug is being developed as a mouth spray to help people suffering from cancer and will be used to relieve their pain. The company plans on bringing out the drug in 2014. GW Pharma got a special exemption from the British government 10 years ago to grow marijuana for research purposes and is now also experimenting with additional derivatives of the plant.
Sativex, as the drug is called, has already been approved in Canada, New Zealand and eight European countries. The drug is as of now being used to relieve muscle spasms caused by multiple sclerosis. The National Multiple Sclerosis Society has not yet endorsed the use of marijuana for MS patients, but it is sponsoring a study by a UC Davis neurologist on a comparison study between marijuana smokers and Marinol with respect to reducing painful muscle spasms.
 |
|||
 |
|
Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!! |
|
Marijuana use for medical purposes is already legal in 16 states and in D.C. on a doctor’s recommendation. But the US Drug Enforcement Administration classifies it as a dangerous drug that has no medical use or value. How the federal government reacts to contradictory claims by two of its departments will be interesting.
Posted by EmploymentCrossing
on January 23, 2012. Filed under Breaking News,Legal News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Attorney Career Resources is sponsored by BCG Attorney Search, the nation's leading placement firm, specializing in law firm placements.
Departures from a law firm are complicated for any attorney, but for a partner the details can be quite intricate. Please note: First and foremost, the interests of your clients should be absolutely paramount. Consultation with existing ABA and state bar guidelines on firm transition is suggested. Below you will find a list of important considerations for partners when changing firms. You will also find suggested practices for maintaining relationships, as well as obligations from a legal and moral perspective. Before You Begin to Meet with New Firms It’s important to review any existing employment agreement with your former firm to make sure you are in compliance with all provisions (pay particular attention to provisions regarding notice). Practice discretion with your existing firm until you [...]
May 23, 2013 Read More
 |
||
| Search Thousands of Legal Jobs | ||
|
Job Type: |
||
 |
||
|
Browse Jobs by Location: |
||
|
||
| Keyword Search: | ||
|
||
Common Sense Police
January 23, 2012 at 5:38 am
I thought marijuana was a schedule 1 drug because it had NO medical value. So once pharmaceutical companies find a way to make a profit, I mean product, out of it then it has medical value? Oh but they still get to keep it on schedule 1 because they say so. I see!
Bill
January 23, 2012 at 6:41 am
Does not work like the REAL thing Peace !!!!!!!